Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CRC--US FDA Approves Opdivo plus Yervoy as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair.
4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners
04:44pm, Friday, 04'th Apr 2025
With some pharmaceutical stocks paying 4% and higher dividends, they may be the perfect total return idea for the rest of 2025.
Hedge Funds Are Dumping Tech Stocks: Grab These 4 Safety Net High-Yield Dividend Giants Now
06:45am, Friday, 04'th Apr 2025
Hedge funds are rapidly reducing their exposure to global information technology stocks, with the latest selloff marking the fastest decline in six months.
Is Bristol Myers Squibb's High-Yielding Dividend Safe?
05:40am, Wednesday, 02'nd Apr 2025
High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on a high yield can be dangerous because if it ends up getting cut, you could
CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo
04:00pm, Tuesday, 01'st Apr 2025
BMY obtains CHMP recommendation for Opdivo for perioperative regimen of neoadjuvant Opdivo and chemotherapy followed by surgery and adjuvant Opdivo for resectable non-small cell lung cancer.
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
02:01pm, Tuesday, 01'st Apr 2025
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are 'underappreciated.'
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Tuesday, 01'st Apr 2025
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Beat the S&P 500 With This Cash-Gushing Dividend Stock
08:00am, Tuesday, 01'st Apr 2025
Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (BMY 1.77%). At the time of writing, shares of the healthcare giant have climbed 4% year to date
Final Trade: DIS, BMY, AMZN, XMAG
06:21pm, Friday, 28'th Mar 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CHMP--BMS Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo and Chemotherapy Followed by Surgery and Adjuvant Opdivo.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CHMP--Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications.
3 Deeply Discounted Dividend Stocks to Buy Today
08:17am, Thursday, 27'th Mar 2025
Want to buy a good dividend stock and secure a great price in the process? I have a list of three stocks that can help you diversify your portfolio, allow you to earn above-average dividends, and scor
Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts
06:46pm, Wednesday, 26'th Mar 2025
Bristol Myers Squibb (BMY) closed the most recent trading day at $59.21, moving +0.03% from the previous trading session.
Bristol-Myers Squibb's Rally Is Well Deserved, Albeit Warranting A Downgrade To Hold
10:22am, Tuesday, 25'th Mar 2025
BMY has enjoyed robust capital appreciation over the past few months, significantly aided by the ongoing market rotation to value/ defensive stocks. This is significantly aided by the double beat FQ4'
Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy
07:21am, Friday, 21'st Mar 2025
Merck and Bristol-Myers Squibb occupy leading positions in the cancer therapy market. Each of them has advantages, as well as dark spots in the portfolio of medications relative to the comparator. In
